These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30058386)

  • 1. Uterine fibroid therapy: the pharmacokinetic considerations.
    Ali M; Al-Hendy A
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):887-889. PubMed ID: 30058386
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibroid growth and medical options for treatment.
    Chabbert-Buffet N; Esber N; Bouchard P
    Fertil Steril; 2014 Sep; 102(3):630-9. PubMed ID: 25171950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine fibroids.
    Pohl O; Zobrist RH; Gotteland JP
    Reprod Sci; 2015 Apr; 22(4):476-83. PubMed ID: 25228633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of uterine fibroids with ulipristal acetate ☆.
    Donnez J; Vázquez F; Tomaszewski J; Nouri K; Bouchard P; Fauser BC; Barlow DH; Palacios S; Donnez O; Bestel E; Osterloh I; Loumaye E;
    Fertil Steril; 2014 Jun; 101(6):1565-73.e1-18. PubMed ID: 24630081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging treatment options for uterine fibroids.
    Donnez J; Arriagada P; Donnez O; Dolmans MM
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):17-23. PubMed ID: 29486606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GnRH analogues and myomas: which strategy?].
    Cohen J
    Gynecol Obstet Fertil; 2006 May; 34(5):462. PubMed ID: 16630742
    [No Abstract]   [Full Text] [Related]  

  • 8. Uterine adenocarcinoma after GnRH agonist treatment.
    Dessole S; Ruiu GA; Cherchi PL; Ambrosini G
    Arch Gynecol Obstet; 2000 Feb; 263(3):148-9. PubMed ID: 10763848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successes and failures of uterine leiomyoma drug discovery.
    Ali M; Chaudhry ZT; Al-Hendy A
    Expert Opin Drug Discov; 2018 Feb; 13(2):169-177. PubMed ID: 29254389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibristal: uterine fibroids' volume reduction].
    Sabourin G
    Perspect Infirm; 2013; 10(5):62. PubMed ID: 24358679
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolapsed leiomyoma with severe haemorrhage after GnRH analogue therapy.
    Kriplani A; Agarwal N; Parul D; Bhatla N; Saxena AK
    J Obstet Gynaecol; 2002 Jul; 22(4):449-51. PubMed ID: 12521484
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids.
    Ferrero S; Vellone VG; Barra F
    Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):107-116. PubMed ID: 29250979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The place of selective progesterone receptor modulators in myoma therapy.
    Donnez J; Donnez O; Courtoy GE; Dolmans MM
    Minerva Ginecol; 2016 Jun; 68(3):313-20. PubMed ID: 26930390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month.
    Hackenberg R; Gesenhues T; Deichert U; Duda V; Schmidt-Rhode P; Schulz KD
    Eur J Obstet Gynecol Reprod Biol; 1992 Jul; 45(2):125-9. PubMed ID: 1386817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormones and pathogenesis of uterine fibroids.
    Reis FM; Bloise E; Ortiga-Carvalho TM
    Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of LHRH analogue action in uterine fibroids.
    Shaw RW
    Horm Res; 1989; 32 Suppl 1():150-3. PubMed ID: 2533145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [GnRH analogues for the treatment of fibroids].
    Murillo EO; Cano A
    Med Clin (Barc); 2013 Jul; 141 Suppl 1():35-9. PubMed ID: 24314566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management of fibroids.
    Sankaran S; Manyonda IT
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
    McClelland HR; Quinn AJ
    Ulster Med J; 1992 Apr; 61(1):51-5. PubMed ID: 1535743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.